-
My Account
co-presented by
In App
My Account
co-presented by
co-presented by
BSE Live
Jan 27, 16:01Prev. Close
163.10
Open Price
163.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 27, 15:59Prev. Close
163.27
Open Price
164.25
Bid Price (Qty.)
161.18 (67)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 24.86 | 5.10 | |
| Net CashFlow From Operating Activities | 12.44 | 4.07 | |
| Net Cash Used In Investing Activities | -27.56 | -2.80 | |
| Net Cash Used From Financing Activities | 21.67 | 7.51 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 6.55 | 8.79 | |
| Cash And Cash Equivalents Begin of Year | -6.43 | -16.89 | |
| Cash And Cash Equivalents End Of Year | 0.12 | -8.10 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y
